Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review

Dipeptidyl Peptidase-4 Inhibitors and Diabetic Kidney Disease: A Narrative Review

Diabetic kidney disease is one of the most frequent complications in patients with diabetes mellitus and affects morbidity and mortality. The recent therapies include oral hypoglycemic drugs that, in addition to optimizing glycemic control and reducing the risk of hypoglycemia, may affect the develo...

Full description

Bibliographic Details
Main Authors: Rodrigo Daza-Arnedo, Jorge-Eduardo Rico-Fontalvo, Nehomar Pájaro-Galvis, Víctor Leal-Martínez, Emilio Abuabara-Franco, María Raad-Sarabia, Juan Montejo-Hernández, María Cardona-Blanco, José Cabrales-Juan, Isabella Uparella-Gulfo, Luis Salgado Montiel
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Kidney Medicine
Subjects:
Diabetic kidney disease
diabetic nephropathy
DPP-4 inhibitors
dipeptidyl peptidase-4
diabetes mellitus
incretin system
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059521002053

Internet

http://www.sciencedirect.com/science/article/pii/S2590059521002053

Similar Items